The question is 'Why'? Granted, I've seen little data on it, but what advantages will it bring vs Actemra? -Not being sarcastic, just don't get it
not being sarcastic either, quite obvious you've been snooping on here for this market shit for months/years.
FDA is concerned about Neurocognitive AEs Evolocumab 27/2976(0.9%) vs 4/1489(0.3%) placebo Alirocumab 18/1550(1.2%) vs 4/788(0.5%) placebo We win! Suck it Amgen!
That's not even remotely statistically significant moron. If you brought that up to anyone, you not only will look like a moron (which you are), but will lose any minute amount of credibility (which you don't have)
I'm with Aegerion, we selling this space. Our product is over 300K a year.... We have narrow indication. Cards. Are writing for a very limited amount of pts. But we get $10,000 commission a pts with our 130K base and a shit load of RSUs. We are paid monthly, I've made between 20-50k a month. So I'm glad your in this space, more noise at there. I only need a hand full of pts to make a lot of money. Good luck and thanks
Your company is scrambling and the stock has dropped significantly. Your RSU's aren't worth a damn. Your CEO is a coke snorting and gangbanging fucktard. Your time for honoring yourself is coming to a close shortly. Good Luck to you D'Bag.